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than Snorkels, Chimneys, or Periscopes in the Treatment of Most
Thoracoabdominal and Juxtarenal Aneurysms
Jason T. Lee
Division of Vascular Surgery, Stanford University Medical Center, 300 Pasteur Drive, Suite H3600, Stanford, CA 94305, USAEndovascular aneurysm repair (EVAR) has rapidly overtaken
open surgery worldwide for the treatment of anatomically
suitable aortic aneurysms. It was inevitable that endovas-
cular technology and strategies would be developed to
further treat juxtarenal (JAA) and thoracoabdominal (TAAA)
aneurysms. Centers of excellence and early adopters
outside the USA and US centers with physician-sponsored
investigator device exemptions gained much experience in
using fenestrated and branched (FEN-BR) devices with
excellent results. However, the lack of widespread avail-
ability of branched devices and the only recent US Food andDrug Administration approval of fenestrated technology in
mid-2012 have encouraged an alternative strategy utilizing
parallel, or snorkel, periscope, and chimney grafts (Ch-
EVAR). The snorkel/chimney/periscope technique has
gained increasing popularity since the ﬁrst publications in
2003 and 2007.1,2 These techniques have emerged from the
basic idea of creating a “snorkel/chimney” conduit from
above or a “periscope” conduit from below using available
“off-the-shelf” stents deployed into target visceral branches
adjacent to the main intra-aortic stent-graft. Initially
described as a bail-out technique for inadvertent coverage
558 Trans-Atlantic Debateor emergent situations, several major centers have reported
excellent short- and mid-term outcomes comparable with
the published literature for FEN-BR technology.1e7
To best address the oft-debated question of FEN-BR
versus Ch-EVAR it is useful to understand ﬁrst that the
best results of FEN-BR come from only a handful of centers
with the longest access and most experience with the de-
vices. Critics of Ch-EVAR claim it remains difﬁcult to obtain a
clear picture of outcomes and its potential applications,
owing to nonstandardized protocols and a heterogeneous
mix of devices used. Concerns raised about Ch-EVAR include
overall technical success, gutter-related type Ia endoleaks
requiring re-interventions, chimney stent patency, long-
term renal dysfunction, and long-term durability. Short of
a randomized prospective trial, however, a direct compari-
son of these techniques is challenging given publication
biases, conﬂicts of interest, and varying lengths of follow-up
time of a given available generation of stent-graft. A review
of numerous meta-analyses and a newly published inter-
national registry of Ch-EVAR provide the most current evi-
dence that it is a viable and often complementary strategy
comparable to FEN-BR repairs in the treatment of patients
with JAA and TAAA.8e11
Available data prior to the PERICLES registry have shown
no statistically signiﬁcant difference between Ch-EVAR and
FEN-BR with regard to technical success, target branch
vessel patency, early mortality, type I endoleak, post-
operative renal dysfunction, or need for secondary inter-
vention.11,12 Still, critics of the Ch-EVAR strategy claim the
majority of the published data are short-term, small in
number, and from single-center experiences. To address this
concern, the PERICLES registry recently reported on 517
patients with 898 chimney stents from 13 international
centers. With regard to overall mortality rates following
FEN-BR, a pooled 30-day mortality of 2.1% was calculated
and noted in a recent systematic review,13 which included
nine studies treating 629 patients. This is slightly better
when compared with the PERICLES registry with its 30-day
mortality of 4.9% (3.7% if ruptured Ch-EVAR was
excluded). In an earlier meta-analysis of published reports
of Ch-EVAR up to 2012,9 an overall pooled 30-day mortality
of 3.4% was noted in 14 studies covering 176 patients. All of
these mortality results are acceptable as most patients with
JAA have signiﬁcant comorbid medical conditions, and the
postoperative mortality is often linked to cardiopulmonary
issues. Interestingly, in one of the few head-to-head pro-
pensity-matched comparisons of endovascular to open
surgery for JAA, FEN-BR had a mortality rate as high as
9.5%, indicating there is a range of mortality for FEN-BR
depending on center experience, as well as patient
selection.14
Re-interventions and branch vessel patency are likely the
main durability issues of any endovascular treatment, and,
particularly for Ch-EVAR and FEN-BR, these issues are
related to type Ia endoleaks and branch patency. Extremely
durable results have been published by the world’s most
experienced FEN-BR center, the Cleveland Clinic, and com-
parison of these results with those of the PERICLES registryis worthwhile.15 In the Cleveland Clinic experience, excel-
lent long-term durability of endovascular repair in 650 pa-
tients (1,679 target vessels) undergoing complex repair with
branched or fenestrated devices between 2001 and 2010
are reported. The 30-day, 1-year, and 5-year freedoms from
branch re-intervention were 98.0%, 94.0%, and 84.0%,
respectively. These numbers from this single institution are
better than those which the PERICLES registry reports.
Overall primary chimney-graft patency was 94.1% with
patency estimates of 94.9%, 91.8%, 89.2%, and 87.0% at 6
months, 1 year, 2 years, and 3 years, respectively, in the 13
centers participating in the registry. However, these excel-
lent Cleveland Clinic branch patency numbers for FEN-BR
are not corroborated by meta-analyses of published re-
ports when more centers are included, suggesting that
“real-world” data cannot match those of the most experi-
enced operators. The earlier-mentioned meta-analysis of
FEN-BR, which included nine studies encompassing 629
patients and a total of 1,622 target vessels, documented a
pooled technical success rate of 90.7% and an estimated re-
intervention rate of 17.8% during a follow-up period of 15e
25 months.13 More importantly, branch vessel patency was
found to be 93.2%, renal function decline 22.2%, and all-
cause morality 16% at the 15e25 month follow-up ran-
gednumbers nearly identical to PERICLES registry results.
Because renal function decline is related not only to pri-
mary patency, but also to complexity of the technical as-
pects of repair, more consistent reporting standards are
likely necessary to truly compare renal outcomes between
FEN-BR and Ch-EVAR. Fortunately, renal function decline
after Ch-EVAR measured by the strictest criteria (stages of
glomerular ﬁltration rate decline range between 17.5% in
the registry and 32.6% in a recent single-center report) is in
line with reported values for FEN-BR.16
In a more recent systematic review and meta-analysis of
FEN-BR the outcomes of 12 studies involving a total of 776
patients and > 1,728 target vessels calculated a pooled esti-
mate for 30-day mortality of 2.5%, technical success of 92.8%,
a short-term 12-month type I endoleak rate of 7.9%, target
vessel patency of 94.5%, and a secondary intervention rate of
17.6%.17 Over 70.0% of the re-interventions occurred during
the ﬁrst year following fenestrated EVAR and loss of renal
artery patency was the leading reason for re-intervention
(24.1%). These pooled results clearly highlight the learning
curve necessary for FEN-BR or any other complex EVAR
strategy. They also emphasize that the results from the most
experienced centers may not be achievable everywhere.
While the data reviewed above have mainly surrounded
JAA treatment, the Ch-EVAR techniques for TAAA typically
involve various sandwich/terrace conﬁgurations of which
extremely limited data exists. Most of these series are case
reports in the setting of urgent or ruptured thor-
acoabdominal pathology, and likely not ready to be
analyzed in comparison with the small experience of a few
centers of excellence with access to branched devices for
TAAA. It remains to be seen whether these strategies that
address aortic pathology well above the visceral segment
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juxtarenal pathology.
One ﬁnal word that deserves mention is the off-the-shelf
availability of the Ch-EVAR strategy, making it applicable
immediately.While technology related to FEN-BRwill continue
to disseminate to all aortic surgeons, the regulatory hurdles,
complex planning required, and the custom-designed wait
period will make it challenging to treat urgent or ruptured
patients. Ch-EVAR naturally adapts to whatever anatomy and
situation that is present, and therefore should be in the
armamentarium of the endovascular aortic specialist.Table 1. Summary of current literature on snorkel/chimney endovascu
Study Patients
(n)
Target vessels
(n)
Technical success
(%)a
30-
(%)
Ohrlander et al.
(2008)18
6 10 100 0.0
Hiramoto et al.
(2009)19
8 8 100 0.0
Bruen et al. (2011)5 21 37 97.3 4.8
Coscas et al. (2011)3 16 26 100 12.5
Resch et al. (2012)21 25 48 100 12.0
Donas et al. (2012)8 39 38 100 0.0
Lee et al. (2012)6 28 56 98.2 7.1
Scali et al. (2014)10 41 76 98.7 4.9
Banno et al.
(2014)20
38 60 97.4 7.9
Lee et al. (2015)11 517 898 97.1 4.9
Note. NR ¼ not reported.
a Rate of successful target vessel cannulation.
b Primary patency rate at follow-up period (months).
Table 2. Summary of current literature on fenestrated endovascular a
Study Patients
(n)
Target vessels
(n)
Technical success
(%)a
Halak et al. (2006)22 17 35 94.1
Muhs et al. (2006)23 38 87 94.0
O’Neill et al. (2006)24 119 302 100
Semmens et al. (2006)25 58 116 82.8
Ziegler et al. (2007)26 60 119 87.3
Scurr et al. (2007)27 45 117 100
Bicknell et al. (2008)28 15 40 93.0
Kristmundsson et al.
(2009)29
54 134 90.7
Greenberg et al.
(2009)30
30 77 100
Chisci et al. (2009)31 52 149 94.2
Amiot et al. (2010)32 134 403 NR
Verhoeven et al.
(2010)33
100 275 94.0
Tambyraja et al. (2011)34 29 79 96.6
Manning et al. (2011)35 20 68 NR
Donas et al. (2012)8 29 44 97.7
Canavati et al. (2013)36 53 160 100
Raux et al. (2014)14 42 121 NR
Lee et al. (2014)16 15 25 96.0
Banno et al. (2014)20 80 194 97.4
Note. NR ¼ not reported.
a Rate of successful target vessel cannulation.
b Early re-intervention within 30 days of operation.In summary, Tables 1 and 2 review ﬁndings from several
studies cited through the meta-analyses presented above to
document the clinical equipoise we have between these
two complementary techniques. The popularity and early
reporting of acceptable outcomes for Ch-EVAR are now
validated in a large registry of 13 centers that demonstrates
comparable technical success, early mortality, overall sur-
vival, freedom from aneurysm-related death, mid-term
branch patency and durability, endoleak rates, and sec-
ondary interventions. Perhaps the most intriguing question
to come from this debate is whether there will be any
impetus to perform a head-to-head controlled comparisonlar aortic aneurysm repair.
d mortality Type 1A endoleak
(%)
Re-intervention
(%)
Primary patency
(%)b
0.0 33.3 100 (2.0 mo)
12.5 NR 100 (12.5 mo)
4.8 NR 84 (12.0 mo)
12.5 12.5 NR
8.0 8.0 98 (10.0 mo)
0.0 3.3 97.4 (NR)
7.1 3.6 98 (3.0 mo)
7.3 4.0 85 (36.0 mo)
5.3 26.3 88 (24.0 mo)
2.9 6.6 94.1 (17.0 mo)
ortic aneurysm repair.
30-d mortality
(%)
Re-intervention
(%)
Primary patency
(%)
1-y patency
(%)
0.0 NR 94.3 NR
2.6 7.9 96.0 96.0
0.8 11.8 100 97.0
3.5 24.1 99.1 89.0
0.0 20.6 96.7 90.5
2.2 13.3 98.3 96.6
0.0 NR 97.0 97.0
3.7 13.0 NR 96.3
0 16.7 100 92.2
5.7 11.5 NR NR
2.2 9.0 98.8 NR
1.0 9.0 98.9 96.4
0.0 37.9 NR 91.8
10.0 NR 96.0 NR
0.0 10.3 96.6 NR
1.9 11.3b NR NR
9.5 NR NR NR
0.0 13.3 96.0 NR
6.3 NR 93.7 NR
560 Trans-Atlantic Debateof these two techniques. Understanding which strategy
might be applicable to which scenario, anatomy, or patient
cohort will likely have the longest positive inﬂuence on the
care of these complex patients. Based on the available ev-
idence at this time, FEN-BR is not always better than the
well-planned Ch-EVAR case, particularly for juxtarenal an-
eurysms, and this review of published literature indicates
that Ch-EVAR and other parallel graft techniques are a
viable treatment method that deserve further study and
potentially wider usage.REFERENCES
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http://dx.doi.org/10.1016/j.ejvs.2015.07.025EDITORS’ COMMENTTrans-Atlantic Debate: Are Branched/Fenestrated EVAR Procedures Better
than Snorkels, Chimneys, or Periscopes in the Treatment of Most
Thoracoabdominal and Juxtarenal Aneurysms?
A.R. Naylor, Editor-in-Chief, European Journal of Vascular and Endovascular Surgery *
Vascular Research Group, Division of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Inﬁrmary, Leicester LE2 7LX, UK
T.L. Forbes, Associate Editor, Journal of Vascular Surgery
Division of Vascular Surgery, University of Toronto, Toronto, ON, CanadaDrs. Haulon and Lee have provided an extensive and broad
comparison of two endovascular approaches to juxtarenal,
pararenal, and thoracoabdominal aortic aneurysms, namely
fenestrated/branched endovascular repairs (FEVAR) or
snorkel/chimney (Ch-EVAR) repairs. Both are respected ex-
perts and leaders in the area of endovascular repair of
complex aortic aneurysms and have advocated strongly for
the responsible reporting and evaluation of the results of
FEVAR and Ch-EVAR.
Although there has been no randomized trial, nor is one
likely needed or possible, several meta-analyses have been
performed to attempt a comparison between these ap-
proaches. Dr. Haulon highlights the difﬁculties in comparing
these approaches as the patients and their anatomies
preclude any meaningful and direct comparison. As both
discussants report, single-center Ch-EVAR experiences tend
to report higher mortality rates and rates of type I endo-
leaks and poorer target vessel patency than FEVAR reports.
However, these differences lessen when emergency cases
are excluded, which are treated in higher proportion in Ch-
EVAR series, and technical features are considered. Both
approaches have beneﬁtted from the expertise of our dis-
cussants as Dr. Haulon has optimized the fenestrated/
branched approach and helps to lead the transition from
solely custom-made devices to the more readily available
off-the-shelf components. Dr. Lee provides important
technical observations of the Ch-EVAR technique regardingthe direct relationship with the number of parallel stents
and risk of type I endoleak (so-called “gutter” endoleaks
due to incomplete conformability of main body and parallel
stents) and the inverse relationship between length of
overlap and target vessel patency.
As expertise in both techniques has developed the dif-
ferences in outcomes and results have become less
apparent. This is evident in the recently published multi-
center, international PERformance of the chimney tech-
nique for the treatment of Complex aortic pathoLogiES
Registry (PERICLES) by Dr. Lee and colleagues.1 This registry
reported on 517 patients treated in US and European cen-
ters over a 6-year period with a mean follow-up of 17.1
months. The results were commendable, but of particular
interest was the variability in devices used. Different main
bodies of commercially available transrenally ﬁxated
endografts were preferred by various centers and different
parallel stents were also used. The uncertainly regarding the
optimum devices is not unique to Ch-EVAR. Such issues as
the use of fenestrations and/or directional side branches
and which is the best bridging stent are issues with FEVAR
that have yet to be fully elucidated. As procedure- or
pathology-speciﬁc devices continue to be developed the
results of both approaches should continue to improve.
Our debaters have eloquently outlined the strengths and
weaknesses of both approaches at the present time. How-
ever, as fenestrated/branched endografts become more
